FDA panel backs Pfizer's low-dose COVID-19 vaccine for kids
Pfizer said its vaccine is 91% effective in preventing Covid-19 in 5- to 11-year-olds; the FDA said its benefit outweighs the risks.
62 across the spectrum. Choose a side on the bar to jump to it.
National story. 174 articles from 63 sources. 62 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated Oct 27, 2021.
Left
15 sourcesAn advisory panel to the FDA recommends Pfizer's vaccine for kids ages 5 to 11
Center
34 sourcesFDA recommends COVID vaccine for youth 5-11, CDC to review next week
An advisory panel to the FDA recommends Pfizer's vaccine for kids ages 5 to 11
Right
13 sourcesFDA advisers back Pfizer/BioNTech COVID-19 vaccine for children
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
3 articlesFDA advisory panel reviews Pfizer’s COVID vaccine for kids ages 5-11
FDA advisers back Pfizer shot for ages 5-11, paving way for Israel to follow
FDA says Pfizer COVID vaccine looks highly effective for children 5-11
Center
0 articlesNone
Right
0 articlesNone
The story so far
3 developments- Oct 23, 2021Only center coverage:FDA scientists say benefits of Pfizer Covid-19 vaccine 'clearly outweigh' the risks for children ages 5 to 11 - STAT
- Oct 25, 2021Children could soon be eligible for Pfizer COVID-19 vaccine
- Oct 26, 2021FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
Who covered each development
No new developments
Quiet for 1822 daysLast development · Oct 26, 2021 — FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids